EPHB6 and breast carcinoma: Consistent with this oncogenic potential of EphB6, its expression was positively correlated with tumor size and recurrence rate of malignant thyroid lesions [29] and was also coupled to poor outcome in breast cancer [30] and tongue squamous cell carcinoma [31].